Initial toxicity study of sangivamycin (NSC-65346).
D000328:Adult; D000368:Aged; D000818:Animals; D000900:Anti-Bacterial Agents / Q000633:toxicity*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D005705:Gallbladder Diseases / Q000139:chemically induced; D017988:Gammaretrovirus / Q000187:drug effects; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D051381:Rats
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents